The University of Chicago Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Stadler, Walter M.
One or more keywords matched the following properties of Stadler, Walter M.
PropertyValue
keywords Bladder Cancer
overview Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research
One or more keywords matched the following items that are connected to Stadler, Walter M.
Item TypeName
Concept Urinary Bladder
Concept Urinary Bladder Neoplasms
Academic Article Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer.
Academic Article Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.
Academic Article Overcoming cellular senescence in human cancer pathogenesis.
Academic Article Expression of bcl-2 and bcl-X in bladder cancer.
Academic Article The 9p21 region in bladder cancer cell lines: large homozygous deletion inactivate the CDKN2, CDKN2B and MTAP genes.
Academic Article Gemcitabine and other new chemotherapeutic agents for the treatment of metastatic bladder cancer.
Academic Article Metastatic bladder cancer: advances in treatment.
Academic Article Loss of the CDKN2A/p16 locus detected in bladder irrigation specimens by fluorescence in situ hybridization.
Academic Article New chemotherapy regimens for advanced bladder cancer.
Academic Article [New chemotherapy regimens for advanced bladder cancer].
Academic Article Alterations of the 9p21 and 9q33 chromosomal bands in clinical bladder cancer specimens by fluorescence in situ hybridization.
Academic Article In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Academic Article Treatment of metastatic urothelial cancer in the post-MVAC era.
Academic Article In vitro evaluation of calphostin C as a novel agent for photodynamic therapy of bladder cancer.
Academic Article Gemcitabine doublets in advanced urothelial cancer.
Academic Article Detection of bladder cancer using a novel nuclear matrix protein, BLCA-4.
Academic Article Perioperative chemotherapy in locally advanced bladder cancer.
Academic Article Long-term survival in phase II trials of gemcitabine plus cisplatin for advanced transitional cell cancer.
Academic Article Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.
Academic Article A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer.
Academic Article Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design.
Academic Article Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study.
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer.
Academic Article Adjuvant chemotherapy in lymph node positive bladder cancer.
Academic Article A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
Academic Article Molecular events in the initiation and progression of bladder-cancer (review).
Academic Article The cure of bladder cancer: the need for multidisciplinary efforts.
Academic Article Integration of neoadjuvant and adjuvant chemotherapy and cystectomy in the treatment of muscle-invasive bladder cancer.
Academic Article Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Academic Article Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Academic Article Increased p16 levels correlate with pRb alterations in human urothelial cells.
Academic Article Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article Phase II trial of cisplatin, gemcitabine, and bevacizumab as first-line therapy for metastatic urothelial carcinoma: Hoosier Oncology Group GU 04-75.
Academic Article ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.
Academic Article Significance of lymphovascular invasion in organ-confined, node-negative urothelial cancer of the bladder: data from the prospective p53-MVAC trial.
Academic Article Variability in surgical quality in a phase III clinical trial of radical cystectomy in patients with organ-confined, node-negative urothelial carcinoma of the bladder.
Academic Article Molecular Drivers of the Non-T-cell-Inflamed Tumor Microenvironment in Urothelial Bladder Cancer.
Academic Article Phase II trial of adjuvant gemcitabine plus cisplatin (GC) with amifostine cytoprotection in patients (pts) with locally advanced bladder cancer (BC).
Academic Article Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer.
Academic Article Management of Urothelial Bladder Cancer: Predicting the Future.
Academic Article Randomized Phase III Trial of Gemcitabine and Cisplatin With Bevacizumab or Placebo in Patients With Advanced Urothelial Carcinoma: Results of CALGB 90601 (Alliance).
Academic Article Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.
Academic Article Bladder-Preserving Trimodality Therapy With Capecitabine.
Search Criteria
  • Bladder